Our latest symposium offers industry professionals and academics the opportunity to hear from the MHRA and experts from the Commission on Human Medicines about the regulatory considerations and support for innovative medicines and emerging technologies. Join us to hear from MHRA experts who will explain how the agency supports innovation in medicines, through scientific and regulatory, advice and guidance. Understand more about our approach to regulation for emerging technologies, including genomics and complex medicinal products and nanomedicines, and take the opportunity to question our expert panel and network with peers in the sector.
Who should attend?
If you work in the pharmaceutical industry or academia to develop innovative medicines, medicinal drug devices or novel manufacturing processes and would like to understand more about the range of advice the MHRA can offer prior to the submission of your licence application and current regulatory considerations in these areas then book your place now.
Benefits of attending:
Discover more about the regulatory perspectives of emerging technologies and innovative medicines Learn about the
MHRA Innovation Office, Scientific Advice Meetings and our Early Access to Medicines Scheme
Network with like-minded peers, share your experiences with colleagues and put questions directly to MHRA experts.
Topics to be covered:
Scientific and regulatory advice from early stage development to regulatory evaluation
Early Access and Adaptive Licensing, including the role of expert committees and the Commission of Human Medicines (CHM)
Regulatory perspectives on innovative medicines and emerging technologies, including modelling and simulation, an overview of drug-device combination products, genomics, complex medicinal products and nanomedicines.
This event will take place at 1VS, The Westminster Conference Centre, London. Places will be allocated on a first-come, first-served basis. We invite you to register by paying by credit card today to save your place and avoid disappointment
Who should attend?
If you work in the pharmaceutical industry or academia to develop innovative medicines, medicinal drug devices or novel manufacturing processes and would like to understand more about the range of advice the MHRA can offer prior to the submission of your licence application and current regulatory considerations in these areas then book your place now.
Benefits of attending:
Discover more about the regulatory perspectives of emerging technologies and innovative medicines Learn about the
MHRA Innovation Office, Scientific Advice Meetings and our Early Access to Medicines Scheme
Network with like-minded peers, share your experiences with colleagues and put questions directly to MHRA experts.
Topics to be covered:
Scientific and regulatory advice from early stage development to regulatory evaluation
Early Access and Adaptive Licensing, including the role of expert committees and the Commission of Human Medicines (CHM)
Regulatory perspectives on innovative medicines and emerging technologies, including modelling and simulation, an overview of drug-device combination products, genomics, complex medicinal products and nanomedicines.
This event will take place at 1VS, The Westminster Conference Centre, London. Places will be allocated on a first-come, first-served basis. We invite you to register by paying by credit card today to save your place and avoid disappointment
